Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs
Clovis Boibessot(Université Laval), Paul Toren(Hôtel-Dieu de Québec)
Cited by 10
Related Papers
Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
|International Journal of Oncology|2014|158
Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer
|PLoS ONE|2016|36
Pre-clinical targeting of enzalutamide-resistant prostate cancer
|cIRcle (University of British Columbia)|2017|0